Jump to content

Draft:Anand Reddi

From Wikipedia, the free encyclopedia
  • Comment: The best way to expedite the review of an uncontroversial submission is to provide minimum 3 high-quality sources with in-depth coverage, rather than including an excessive number of references. For instance, Anand Reddi is a health system strengthening expert, global health specialist and public health advocate... needs only 1-2 refs rather than [1][2][3][4][5][6][7]. Please see WP:CITEKILL for future reference. TheBirdsShedTears (talk) 15:24, 15 November 2024 (UTC)
  • Comment: Thanks for the excellent feedback. Will apply. This article has been completely rewritten per editorial feedback and past comments from the previous deletion. Thank you @Asilvering 💬 17:47, 28 October 2024 (UTC)
  • Comment: You can put links in the references only if they support the content in the sentence the reference is attached to. So the external links I was talking about before wouldn't be good as references. If you think they're relevant enough to belong in a separate External links section, you can put them there. asilvering (talk) 20:10, 27 October 2024 (UTC)
  • Comment: just a quick note: no external links in body of articles, see WP:EL for more info asilvering (talk) 22:36, 25 October 2024 (UTC)
  • Comment: This article has been completely rewritten per editorial feedback and past comments from the previous deletion. Thank you @SafariScribe and @CFA for the excellent feedback and very thoughtful responses to improve the article. 1. The references have been improved including notable 3rd party new sources since the initial submission per @SafariScribe. 2. The draft has been significantly re-written to reflect the past editorial comments @CFA💬 17:47, 11 October 2024 (UTC)
Anand Reddi
Born
Maryland, USA
NationalityAmerican
EducationUniversity of Michigan, Ann Arbor, University of Colorado School of Medicine
Occupation(s)Global Health Policy Specialist, Public Health Advocate, Biotech Executive
Known forAdvocacy in global HIV/AIDS treatment and health systems strengthening
AwardsFulbright Scholar, American Medical Association Foundation Leadership Award

Anand Reddi is a health system strengthening expert focusing on global health and public health advocacy. His work focused on global HIV scale-up including the President's Emergency Plan for AIDS Relief (PEPFAR).[1][2][3] Additionally, he is active in advancing public-private global health partnerships with biotech to support access to essential medicines.[4][5]

Early Life and Education

[edit]

Reddi pursued his undergraduate studies in history and biology at the University of Michigan, Ann Arbor and a medical degree at the University of Colorado School of Medicine.[6] He was a Fulbright Scholar to KwaZulu-Natal, South Africa, focusing on pediatric antiretroviral scale-up under the research mentorship of Hoosen Coovadia at the PEPFAR funded Sinikithemba HIV/AIDS clinic at McCord Zulu Hospital.[7]

Global Health

[edit]

HIV Implementation Science

[edit]

In the early 2000s it was uncertain if the provision of antiretroviral therapy in resource limited settings such as Southern Africa was feasible.[8][9] Reddi's research documented that antiretroviral therapy is effective despite the challenges of a resource limited setting.[10][11] These data were important in providing implementation experience for HIV scale-up initiatives advanced by PEPFAR and The Global Fund.[12][13]

U.S. HIV Global Health Funding and Advocacy

[edit]

In May 2009, the Obama administration's introduced a global health initiative that de-prioritized global HIV funding by prioritizing funding for maternal and child health programs.[14][15] Ezekiel Emanuel, the initiative’s architect and a special advisor to President Obama on health policy, argued that PEPFAR “is not the best use of international health funding” and “fails to address many of the developing world’s most serious health issues.”[16] Reddi challenged Dr. Emanuel's position on PEPFAR by arguing maternal and child health need not be framed in opposition to PEPFAR.[17][18][19] Reddi and Archbishop Desmond Tutu alongside other HIV advocates rebutted Emanuel's arguments that resulted in the restoration of $366 million for antiretroviral scale-up to Uganda in 2010.[20][21] The opinion pieces in The Huffington Post, The New York Times and The Washington Post facilitated the movement to drive the Obama administrations' reversal on global HIV funding.[22][23]

HIV Pre-exposure Prophylaxis Access

[edit]

The AIDS Healthcare Foundation (AHF) launched a campaign against the Food and Drug Administration review of Truvada for use as a HIV Pre-exposure Prophylaxis (PrEP) drug.[24] Reddi resigned from the Board of Directors of AHF over their opposition to HIV PrEP writing: "AHF’s media campaign against FDA review of PrEP is myopic, blinded by its determination to derail a promising new medication."[25] The resulting advocacy was validated by the 2015 decision by the World Health Organization to recommended that people at substantial risk of HIV infection should be offered tenofovir disoproxil fumarate (TDF)-based oral PrEP as an additional HIV prevention option.[26]

Human capital contracts

[edit]

To address healthcare worker shortages in resource-limited settings, Reddi proposed using human capital contracts inspired by Nobel Prize in Economic Sciences winner Milton Friedman.[27][28][29] Under this model, an investor—such as a donor nation, foundation, or global health initiative—would fund a student’s medical training in exchange for 10 years of service in government or NGO clinics within their home country. Medical licenses would be tied to this commitment, and a multilateral agreement could curb migration during the service period to address “brain drain.”[30]

HIV Test & Treat

[edit]

Reddi led a major HIV Test & Treat initiative in Shinyanga, Tanzania, partnering with Gilead Sciences, The Vatican, the Tanzanian government, and NGOs like Doctors with Africa CUAMM and Joep Lange's Amsterdam Institute of Global Health.[2][31] The project reached over 300,000 people through decentralized outreach, linking those testing positive to care. Between May 2017 and June 2019, 255,329 HIV tests were conducted, with a positivity rate of 1.2%.[32]

Awards

[edit]

Reddi received the Atlantic Dialogues Emerging Leader Award, the American Medical Association Foundation Leadership Award and the Fulbright Scholarship to South Africa for his contributions in global health policy and HIV/AIDS treatment and advocacy.[33]

[edit]

Anand Reddi's Contributions to Huffington Post

References

[edit]
  1. ^ Nuki, Paul; Townsley, Simon (18 July 2018). "HIV and Aids in Africa has a new adversary – God and big pharma". The Telegraph.
  2. ^ a b Ratcliffe, Rebecca (22 July 2018). "Biker nun on a mission to free Tanzania from grip of HIV". The Guardian.
  3. ^ Liu, Richard (19 November 2020). "Atlantic Dialogues Talks 2020: Health Capacities as a New Power Instrument". The Atlantic Dialogues: Policy Center for the New South.
  4. ^ "Pharma companies are capitalizing on Covid-19 restrictions to promote unbranded campaigns". Pharmaceutical Technology Review. Retrieved 23 July 2024.
  5. ^ Bulik, Beth Snyder (28 Oct 2020). "BI, Gilead execs highlight value of disease awareness campaigns—particularly during the pandemic". Fierce Pharma.
  6. ^ "Anand Reddi, Director of Hepion Pharmaceuticals Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934". UNITED STATES SECURITIES AND EXCHANGE COMMISSION.
  7. ^ Reddi, Anand; Leeper, Sarah C.; Grobler, Anneke C.; Geddes, Rosemary; France, K Holly; Dorse, Gillian L.; Vlok, Willem J.; Mntambo, Mbali; Thomas, Monty; Nixon, Kristy; Holst, Helga L.; Karim, Quarraisha Abdool; Rollins, Nigel C.; Coovadia, Hoosen M.; Giddy, Janet (17 March 2017). "Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa". BMC Pediatrics. 7 (12): 13. doi:10.1186/1471-2431-7-13. PMC 1847430. PMID 17367540.
  8. ^ Herbert, Bob (11 June 2001). "In America; Refusing To Save Africans". The New York Times.
  9. ^ "U.S. Global Health Policy: HIV/AIDS at a Crossroads Initial Accomplishments Threatened by Policy Changes". University of Colorado School of Medicine. CU Medicine Today. Retrieved 6 July 2024.
  10. ^ Purvis, Katherine. "How do we increase the HIV response with limited funds?". The Guardian. Retrieved 6 July 2024.
  11. ^ Banning-Lover, Rachel. "What is the best model to bring healthcare to all?". The Guardian. Retrieved 19 June 2024.
  12. ^ Leeper, Sarah C.; Reddi, Anand (2010-09-10). "United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR)". AIDS. 24 (14): 2145–2149. doi:10.1097/QAD.0b013e32833cbb41. ISSN 0269-9370. PMID 20606571.
  13. ^ Judem, Emily. "An invisible issue: The presidential campaign and HIV/AIDS". The World Radio Program.
  14. ^ Bendavid, Eran; Miller, Grant (2010-08-18). "The US Global Health Initiative: Informing Policy With Evidence". JAMA. 304 (7): 791–792. doi:10.1001/jama.2010.1189. ISSN 0098-7484. PMC 3816172. PMID 20716743.
  15. ^ D'Almeida, Kanya. "Obama AIDS Plan Stumbles over Funding". Global Issues. Inter Press Service. Retrieved 19 June 2024.
  16. ^ Denny, Colleen C.; Emanuel, Ezekiel J. (2008-11-05). "US Health Aid Beyond PEPFAR: The Mother & Child Campaign". JAMA. 300 (17): 2048–2051. doi:10.1001/jama.2008.556. ISSN 0098-7484. PMID 18984893.
  17. ^ "United States Global Health Policy: HIV/AIDS Treatment Funding At Risk Under President Obama". The Huffington Post. 21 June 2010.
  18. ^ Khan, Azmat (19 July 2012). "What Is President Obama's Track Record on HIV/AIDS?". Frontline (PBS).
  19. ^ Mungcal, Ivy (22 July 2010). "Eric Goosby, Bill Clinton Defend Obama's AIDS Funding Decisions". Devex.
  20. ^ Tutu, Desmond (2010-07-21). "Opinion | Obama's Overdue AIDS Bill". The New York Times. ISSN 0362-4331. Retrieved 2024-08-12.
  21. ^ Mungcal, Ivy (23 July 2010). "Obama Promises to Step Up AIDS Fight". Devex.
  22. ^ "Aids: Time to Refocus (2 Letters)". The New York Times. 1 Nov 2010.
  23. ^ "AIDS/HIV funding must be a priority for the U.S." The Washington Post. 3 August 2010.
  24. ^ "AHF to Gilead: "No Magic Pill" Ads Warn against AIDS Drug as HIV Prevention". AIDS Healthcare Foundation. 9 March 2011.
  25. ^ "Moving Forward on FDA Review of HIV Prevention Drugs". The Huffington Post. 2 Nov 2011.
  26. ^ World Health Organization. "Pre-exposure prophylaxis (PrEP)". Global HIV Program: PrEP. Retrieved 12 June 2024.
  27. ^ "Global Health Service Corps Essential To Improve African Health Systems, Achieve 'AIDS-Free Generation'". Kaiser Family Foundation.
  28. ^ "Healthcare Reform: Solving the Medical Student Debt Crisis Through Human Capital Contracts". The Huffington Post.
  29. ^ Weinstein, Louis; Wolfe, Honor (1 July 2010). "A unique solution to solve the pending medical school tuition crisis". American Journal of Obstetrics and Gynecology. 203 (1): 19.e1–19.e3. doi:10.1016/j.ajog.2009.11.019. PMID 20035918.
  30. ^ Reddi, A.; Thyssen, A.; Smith, D.; Lange, J. H.; Akileswaran, C. (2012). "Human capital contracts for global health: a plan to increase the number of physicians in resource limited settings". AIDS. 26 (15): 1979–1980. doi:10.1097/QAD.0b013e32835857d4. PMID 22992581.
  31. ^ Tanzania, World Health Organization. "The Tanzania Catholic Church launches the Test and Treat Project". WHO Tanzania. Retrieved 12 June 2024.
  32. ^ Martelli, Giulia; Van Duffel, Lukas; Kwezi, Edith Cosmas; Cavallin, Francesco; Salehe, Idd Amiri; Torelli, Giovanni F.; Putoto, Giovanni; Hermans, Sabine; Rinke De Wit, Tobias F.; Pozniak, Anton (2022). "Community- and facility-based HIV testing interventions in northern Tanzania: Midterm results of Test & Treat Project". PLOS ONE. 17 (4): e0266870. Bibcode:2022PLoSO..1766870M. doi:10.1371/journal.pone.0266870. PMC 9004748. PMID 35413074.
  33. ^ "Achievements in academics, service recognized with CU's 2013 Jefferson Award". University of Colorado. Retrieved 7 July 2024.
Scholia has a profile for Anand Reddi (Q48436054).
Scholia has a profile for Anand Reddi (Q4751276).

Category:HIV/AIDS researchersCategory:University of Michigan alumniCategory:University of Colorado School of Medicine alumniCategory:American scientistsCategory:Scientists from MarylandCategory:21st-century scientistsCategory:Living people Category:Year of birth missing (living people) Category:American HIV/AIDS activists Category:American health activistsCategory:HIV/AIDS researchers Category:University of Michigan alumni Category:University of Colorado School of Medicine alumni Category:American scientists Category:Scientists from Maryland Category:21st-century scientists Category:Living people Category:Year of birth missing (living people) Category:American HIV/AIDS activists Category:American health activists

Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Anand_Reddi&oldid=1258433736"